类药物合物:针对性癌症治疗的新范式
Mo Wang1, Jiawei Liu1, Mingjing Xia1
1Ministry of Education Key Laboratory of Molecular and Cellular Biology; Hebei Anti-Tumor Molecular Target Technology Innovation Center; Hebei Research Center of the Basic Discipline of Cell Biology; College of Life Science, Hebei Normal University, Shijiazhuang, 050024, PR China.
类药物合物 (PDC) 对抗体药物合物 (ADC) 在向癌症治疗中具有优势. 本次审查强调了PDC的进展,稳定性挑战以及未来发展的计算策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物结合化学 生物结合化学
背景情况:
- 类药物联合体 (PDCs) 正在成为一个有前途的向治疗模式,继抗体药物联合体 (ADCs) 之后.
- 与ADC相比,PDCs提供了优势,包括加强组织透,简化合成和降低制造成本.
- 两种PDC被FDA批准用于癌症治疗,显示出显著的治疗潜力.
研究的目的:
- 系统地审查针对癌细胞的PDC的最新进展.
- 解决与PDC稳定性,药理动力学以及研究和开发时间表相关的挑战.
- 探索计算技术在帮助PDC发展中的作用,并确定未来的研究方向.
主要方法:
- 综合文献综述,重点关注PDC结构功能关系.
- 对癌细胞向 (CTP) 选择的最新研究进行分析.
- 关于PDCs的药理动力学特征和稳定性调节的研究的评估.
主要成果:
- PDC表现出显著的治疗效果,但面临着诸如稳定性差,循环时间短等挑战.
- 在CTP选择和理解药物动力学特征方面的进展对于疗效至关重要.
- 稳定性监管战略是克服局限性的关键.
结论:
- PDCs代表了向癌症治疗的重大进步,提供了明显的优势.
- 解决稳定性和药理动力学的问题对于临床成功至关重要.
- 计算方法和持续的研究对于优化PDC开发和应用至关重要.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
